Justin D. Gover - 09 Sep 2025 Form 4 Insider Report for Design Therapeutics, Inc. (DSGN)

Role
Director
Signature
/s/ Mustapha Parekh, Attorney-in-Fact
Issuer symbol
DSGN
Transactions as of
09 Sep 2025
Net transactions value
$0
Form type
4
Filing time
10 Sep 2025, 17:18:17 UTC
Previous filing
30 Jul 2025
Next filing
05 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Gover Justin D. Director C/O DESIGN THERAPEUTICS, INC., 6005 HIDDEN VALLEY ROAD, SUITE 110, CARLSBAD /s/ Mustapha Parekh, Attorney-in-Fact 10 Sep 2025 0001754129

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DSGN Stock option (right to buy) Award $0 +30,000 $0.000000 30,000 09 Sep 2025 Common Stock 30,000 $6.64 Direct F1
transaction DSGN Stock option (right to buy) Award $0 +15,833 $0.000000 15,833 09 Sep 2025 Common Stock 15,833 $6.64 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will vest in equal monthly installments over 36 months following September 9, 2025.
F2 The shares subject to the option will vest in equal monthly installments over 12 months following September 9, 2025.